# OA04.03 Mobocertinib in NSCLC With EGFR Exon 20 Insertions: Results From EXCLAIM and Pooled Platinum-Pretreated Patient Populations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oa04-03-mobocertinib-in-nsclc-with-egfr-exon-20-insertions-results-from-exclaim/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C. Zhou,Suresh S. Ramalingam,B. Li,Jian Fang,T.M. Kim,Sejoong Kim,James Chih‐Hsin Yang,Gregory J. Riely,Tarek Mekhail,Danny Nguyen,M.R. García Campelo,Enriqueta Felip,Shu Jin,Veronica Bunn,Jianchang Lin,Hui‐Ming Lin,Minal Mehta,Pasi A. Jänne |
| Citations | 28 |
| DOI | 10.1016/j.jtho.2021.01.283 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086421003257/pdf |
| OpenAlex ID | https://openalex.org/W3136657158 |
| Type | conference-abstract |
| Year | 2021 |

## Paper authors

- [C. Zhou](https://scholariq.org/researchers/c-zhou/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.